img

Global Interferon Beta-1a Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Interferon Beta-1a Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Interferon Beta-1a report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Interferon Beta-1a market is projected to reach US$ 2584.8 million in 2029, increasing from US$ 4324 million in 2022, with the CAGR of -7.1% during the period of 2024 to 2029. Demand from Hospital and Drugs Store are the major drivers for the industry.
Interferon Beta-1a is a medication used for the treatment of relapsing forms of multiple sclerosis (MS). The market for Avonex is driven by factors such as the increasing prevalence of MS, the growing awareness about the disease, and advancements in MS treatment. Avonex is a well-established therapy with a proven track record of efficacy and safety. The market is also influenced by factors such as healthcare infrastructure development, favorable reimbursement policies, and the availability of generic alternatives. However, the market faces challenges such as competition from other MS treatments and the introduction of newer therapies. Despite these challenges, Avonex continues to hold a significant market share due to its established reputation and effectiveness. As research and development in the field of MS continue, the Avonex market is expected to witness moderate growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Interferon Beta-1a market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biogen
CinnaGen
Merck KGaA
Teva
Novartis
Bayer
Sanofi
Acorda Therapeutics
Mallinckrodt
Segment by Type
Subcutaneous
Intramuscular

Segment by Application


Hospital
Drugs Store
Other

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Interferon Beta-1a market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Interferon Beta-1a, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Interferon Beta-1a industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Interferon Beta-1a in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Interferon Beta-1a introduction, etc. Interferon Beta-1a Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Interferon Beta-1a market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Interferon Beta-1a Market Overview
1.1 Interferon Beta-1a Product Overview
1.2 Interferon Beta-1a Market Segment by Type
1.2.1 Subcutaneous
1.2.2 Intramuscular
1.3 Global Interferon Beta-1a Market Size by Type
1.3.1 Global Interferon Beta-1a Market Size Overview by Type (2018-2029)
1.3.2 Global Interferon Beta-1a Historic Market Size Review by Type (2018-2024)
1.3.3 Global Interferon Beta-1a Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Interferon Beta-1a Sales Breakdown by Type (2018-2024)
1.4.2 Europe Interferon Beta-1a Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Interferon Beta-1a Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Interferon Beta-1a Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Interferon Beta-1a Sales Breakdown by Type (2018-2024)
2 Global Interferon Beta-1a Market Competition by Company
2.1 Global Top Players by Interferon Beta-1a Sales (2018-2024)
2.2 Global Top Players by Interferon Beta-1a Revenue (2018-2024)
2.3 Global Top Players by Interferon Beta-1a Price (2018-2024)
2.4 Global Top Manufacturers Interferon Beta-1a Manufacturing Base Distribution, Sales Area, Product Type
2.5 Interferon Beta-1a Market Competitive Situation and Trends
2.5.1 Interferon Beta-1a Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Interferon Beta-1a Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interferon Beta-1a as of 2022)
2.7 Date of Key Manufacturers Enter into Interferon Beta-1a Market
2.8 Key Manufacturers Interferon Beta-1a Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Interferon Beta-1a Status and Outlook by Region
3.1 Global Interferon Beta-1a Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Interferon Beta-1a Historic Market Size by Region
3.2.1 Global Interferon Beta-1a Sales in Volume by Region (2018-2024)
3.2.2 Global Interferon Beta-1a Sales in Value by Region (2018-2024)
3.2.3 Global Interferon Beta-1a Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Interferon Beta-1a Forecasted Market Size by Region
3.3.1 Global Interferon Beta-1a Sales in Volume by Region (2024-2029)
3.3.2 Global Interferon Beta-1a Sales in Value by Region (2024-2029)
3.3.3 Global Interferon Beta-1a Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Interferon Beta-1a by Application
4.1 Interferon Beta-1a Market Segment by Application
4.1.1 Hospital
4.1.2 Drugs Store
4.1.3 Other
4.2 Global Interferon Beta-1a Market Size by Application
4.2.1 Global Interferon Beta-1a Market Size Overview by Application (2018-2029)
4.2.2 Global Interferon Beta-1a Historic Market Size Review by Application (2018-2024)
4.2.3 Global Interferon Beta-1a Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Interferon Beta-1a Sales Breakdown by Application (2018-2024)
4.3.2 Europe Interferon Beta-1a Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Interferon Beta-1a Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Interferon Beta-1a Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Interferon Beta-1a Sales Breakdown by Application (2018-2024)
5 North America Interferon Beta-1a by Country
5.1 North America Interferon Beta-1a Historic Market Size by Country
5.1.1 North America Interferon Beta-1a Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Interferon Beta-1a Sales in Volume by Country (2018-2024)
5.1.3 North America Interferon Beta-1a Sales in Value by Country (2018-2024)
5.2 North America Interferon Beta-1a Forecasted Market Size by Country
5.2.1 North America Interferon Beta-1a Sales in Volume by Country (2024-2029)
5.2.2 North America Interferon Beta-1a Sales in Value by Country (2024-2029)
6 Europe Interferon Beta-1a by Country
6.1 Europe Interferon Beta-1a Historic Market Size by Country
6.1.1 Europe Interferon Beta-1a Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Interferon Beta-1a Sales in Volume by Country (2018-2024)
6.1.3 Europe Interferon Beta-1a Sales in Value by Country (2018-2024)
6.2 Europe Interferon Beta-1a Forecasted Market Size by Country
6.2.1 Europe Interferon Beta-1a Sales in Volume by Country (2024-2029)
6.2.2 Europe Interferon Beta-1a Sales in Value by Country (2024-2029)
7 Asia-Pacific Interferon Beta-1a by Region
7.1 Asia-Pacific Interferon Beta-1a Historic Market Size by Region
7.1.1 Asia-Pacific Interferon Beta-1a Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Interferon Beta-1a Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Interferon Beta-1a Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Interferon Beta-1a Forecasted Market Size by Region
7.2.1 Asia-Pacific Interferon Beta-1a Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Interferon Beta-1a Sales in Value by Region (2024-2029)
8 Latin America Interferon Beta-1a by Country
8.1 Latin America Interferon Beta-1a Historic Market Size by Country
8.1.1 Latin America Interferon Beta-1a Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Interferon Beta-1a Sales in Volume by Country (2018-2024)
8.1.3 Latin America Interferon Beta-1a Sales in Value by Country (2018-2024)
8.2 Latin America Interferon Beta-1a Forecasted Market Size by Country
8.2.1 Latin America Interferon Beta-1a Sales in Volume by Country (2024-2029)
8.2.2 Latin America Interferon Beta-1a Sales in Value by Country (2024-2029)
9 Middle East and Africa Interferon Beta-1a by Country
9.1 Middle East and Africa Interferon Beta-1a Historic Market Size by Country
9.1.1 Middle East and Africa Interferon Beta-1a Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Interferon Beta-1a Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Interferon Beta-1a Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Interferon Beta-1a Forecasted Market Size by Country
9.2.1 Middle East and Africa Interferon Beta-1a Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Interferon Beta-1a Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Biogen
10.1.1 Biogen Company Information
10.1.2 Biogen Introduction and Business Overview
10.1.3 Biogen Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Biogen Interferon Beta-1a Products Offered
10.1.5 Biogen Recent Development
10.2 CinnaGen
10.2.1 CinnaGen Company Information
10.2.2 CinnaGen Introduction and Business Overview
10.2.3 CinnaGen Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CinnaGen Interferon Beta-1a Products Offered
10.2.5 CinnaGen Recent Development
10.3 Merck KGaA
10.3.1 Merck KGaA Company Information
10.3.2 Merck KGaA Introduction and Business Overview
10.3.3 Merck KGaA Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck KGaA Interferon Beta-1a Products Offered
10.3.5 Merck KGaA Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Teva Interferon Beta-1a Products Offered
10.4.5 Teva Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis Interferon Beta-1a Products Offered
10.5.5 Novartis Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bayer Interferon Beta-1a Products Offered
10.6.5 Bayer Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Interferon Beta-1a Products Offered
10.7.5 Sanofi Recent Development
10.8 Acorda Therapeutics
10.8.1 Acorda Therapeutics Company Information
10.8.2 Acorda Therapeutics Introduction and Business Overview
10.8.3 Acorda Therapeutics Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Acorda Therapeutics Interferon Beta-1a Products Offered
10.8.5 Acorda Therapeutics Recent Development
10.9 Mallinckrodt
10.9.1 Mallinckrodt Company Information
10.9.2 Mallinckrodt Introduction and Business Overview
10.9.3 Mallinckrodt Interferon Beta-1a Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Mallinckrodt Interferon Beta-1a Products Offered
10.9.5 Mallinckrodt Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Interferon Beta-1a Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Interferon Beta-1a Industrial Chain Analysis
11.4 Interferon Beta-1a Market Dynamics
11.4.1 Interferon Beta-1a Industry Trends
11.4.2 Interferon Beta-1a Market Drivers
11.4.3 Interferon Beta-1a Market Challenges
11.4.4 Interferon Beta-1a Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Interferon Beta-1a Distributors
12.3 Interferon Beta-1a Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Subcutaneous
Table 2. Major Company of Intramuscular
Table 3. Global Interferon Beta-1a Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 5. Global Interferon Beta-1a Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Interferon Beta-1a Sales by Type (2018-2024) & (US& Million)
Table 7. Global Interferon Beta-1a Market Share in Value by Type (2018-2024)
Table 8. Global Interferon Beta-1a Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Interferon Beta-1a Sales by Type (2024-2029) & (K Units)
Table 10. Global Interferon Beta-1a Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Interferon Beta-1a Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Interferon Beta-1a Sales Market Share in Value by Type (2024-2029)
Table 13. Global Interferon Beta-1a Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Interferon Beta-1a Sales by Type (2018-2024) & (K Units)
Table 15. North America Interferon Beta-1a Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Interferon Beta-1a Sales (K Units) by Type (2018-2024)
Table 17. Europe Interferon Beta-1a Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Interferon Beta-1a Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Interferon Beta-1a Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Interferon Beta-1a Sales (K Units) by Type (2018-2024)
Table 21. Latin America Interferon Beta-1a Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Interferon Beta-1a Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Interferon Beta-1a Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Interferon Beta-1a Sales by Company (2018-2024) & (K Units)
Table 25. Global Interferon Beta-1a Sales Share by Company (2018-2024)
Table 26. Global Interferon Beta-1a Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Interferon Beta-1a Revenue Share by Company (2018-2024)
Table 28. Global Market Interferon Beta-1a Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Interferon Beta-1a Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Interferon Beta-1a Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Interferon Beta-1a as of 2022)
Table 32. Date of Key Manufacturers Enter into Interferon Beta-1a Market
Table 33. Key Manufacturers Interferon Beta-1a Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Interferon Beta-1a Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Interferon Beta-1a Sales by Region (2018-2024) & (K Units)
Table 37. Global Interferon Beta-1a Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Interferon Beta-1a Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Interferon Beta-1a Sales Market Share in Value by Region (2018-2024)
Table 40. Global Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Interferon Beta-1a Sales by Region (2024-2029) & (K Units)
Table 42. Global Interferon Beta-1a Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Interferon Beta-1a Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Interferon Beta-1a Sales Market Share in Value by Region (2024-2029)
Table 45. Global Interferon Beta-1a Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Interferon Beta-1a Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Interferon Beta-1a Sales by Application (2018-2024) & (K Units)
Table 48. Global Interferon Beta-1a Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Interferon Beta-1a Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Interferon Beta-1a Sales Market Share in Value by Application (2018-2024)
Table 51. Global Interferon Beta-1a Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Interferon Beta-1a Sales by Application (2024-2029) & (K Units)
Table 53. Global Interferon Beta-1a Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Interferon Beta-1a Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Interferon Beta-1a Sales Market Share in Value by Application (2024-2029)
Table 56. Global Interferon Beta-1a Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Interferon Beta-1a Sales by Application (2018-2024) (K Units)
Table 58. North America Interferon Beta-1a Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Interferon Beta-1a Sales by Application (2018-2024) (K Units)
Table 60. Europe Interferon Beta-1a Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Interferon Beta-1a Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Interferon Beta-1a Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Interferon Beta-1a Sales by Application (2018-2024) (K Units)
Table 64. Latin America Interferon Beta-1a Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Interferon Beta-1a Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Interferon Beta-1a Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Interferon Beta-1a Sales by Country (2018-2024) & (K Units)
Table 68. North America Interferon Beta-1a Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Interferon Beta-1a Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Interferon Beta-1a Sales Market Share in Value by Country (2018-2024)
Table 71. North America Interferon Beta-1a Sales by Country (2024-2029) & (K Units)
Table 72. North America Interferon Beta-1a Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Interferon Beta-1a Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Interferon Beta-1a Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Interferon Beta-1a Sales by Country (2018-2024) & (K Units)
Table 76. Europe Interferon Beta-1a Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Interferon Beta-1a Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Interferon Beta-1a Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Interferon Beta-1a Sales by Country (2024-2029) & (K Units)
Table 80. Europe Interferon Beta-1a Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Interferon Beta-1a Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Interferon Beta-1a Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Interferon Beta-1a Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Interferon Beta-1a Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Interferon Beta-1a Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Interferon Beta-1a Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Interferon Beta-1a Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Interferon Beta-1a Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Interferon Beta-1a Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Interferon Beta-1a Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Interferon Beta-1a Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Interferon Beta-1a Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Interferon Beta-1a Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Interferon Beta-1a Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Interferon Beta-1a Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Interferon Beta-1a Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Interferon Beta-1a Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Interferon Beta-1a Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Interferon Beta-1a Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Interferon Beta-1a Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Interferon Beta-1a Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Interferon Beta-1a Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Interferon Beta-1a Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Interferon Beta-1a Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Interferon Beta-1a Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Interferon Beta-1a Sales Market Share in Value by Country (2024-2029)
Table 107. Biogen Company Information
Table 108. Biogen Introduction and Business Overview
Table 109. Biogen Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Biogen Interferon Beta-1a Product
Table 111. Biogen Recent Development
Table 112. CinnaGen Company Information
Table 113. CinnaGen Introduction and Business Overview
Table 114. CinnaGen Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. CinnaGen Interferon Beta-1a Product
Table 116. CinnaGen Recent Development
Table 117. Merck KGaA Company Information
Table 118. Merck KGaA Introduction and Business Overview
Table 119. Merck KGaA Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Merck KGaA Interferon Beta-1a Product
Table 121. Merck KGaA Recent Development
Table 122. Teva Company Information
Table 123. Teva Introduction and Business Overview
Table 124. Teva Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Teva Interferon Beta-1a Product
Table 126. Teva Recent Development
Table 127. Novartis Company Information
Table 128. Novartis Introduction and Business Overview
Table 129. Novartis Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Novartis Interferon Beta-1a Product
Table 131. Novartis Recent Development
Table 132. Bayer Company Information
Table 133. Bayer Introduction and Business Overview
Table 134. Bayer Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Bayer Interferon Beta-1a Product
Table 136. Bayer Recent Development
Table 137. Sanofi Company Information
Table 138. Sanofi Introduction and Business Overview
Table 139. Sanofi Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Sanofi Interferon Beta-1a Product
Table 141. Sanofi Recent Development
Table 142. Acorda Therapeutics Company Information
Table 143. Acorda Therapeutics Introduction and Business Overview
Table 144. Acorda Therapeutics Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Acorda Therapeutics Interferon Beta-1a Product
Table 146. Acorda Therapeutics Recent Development
Table 147. Mallinckrodt Company Information
Table 148. Mallinckrodt Introduction and Business Overview
Table 149. Mallinckrodt Interferon Beta-1a Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Mallinckrodt Interferon Beta-1a Product
Table 151. Mallinckrodt Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Interferon Beta-1a Market Trends
Table 155. Interferon Beta-1a Market Drivers
Table 156. Interferon Beta-1a Market Challenges
Table 157. Interferon Beta-1a Market Restraints
Table 158. Interferon Beta-1a Distributors List
Table 159. Interferon Beta-1a Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Interferon Beta-1a Product Picture
Figure 2. Global Interferon Beta-1a Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Interferon Beta-1a Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Interferon Beta-1a Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Subcutaneous
Figure 6. Global Subcutaneous Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Intramuscular
Figure 8. Global Intramuscular Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Interferon Beta-1a Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Interferon Beta-1a Sales Market Share by Type in 2022 & 2029
Figure 11. North America Interferon Beta-1a Sales Market Share in Volume by Type in 2022
Figure 12. North America Interferon Beta-1a Sales Market Share in Value by Type in 2022
Figure 13. Europe Interferon Beta-1a Sales Market Share in Volume by Type in 2022
Figure 14. Europe Interferon Beta-1a Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Interferon Beta-1a Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Interferon Beta-1a Sales Market Share in Value by Type in 2022
Figure 17. Latin America Interferon Beta-1a Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Interferon Beta-1a Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Interferon Beta-1a Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Interferon Beta-1a Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Interferon Beta-1a Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Interferon Beta-1a Revenue in 2022
Figure 23. Interferon Beta-1a Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Drugs Store
Figure 27. Global Drugs Store Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Interferon Beta-1a Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Interferon Beta-1a Sales Market Share by Application in 2022 & 2029
Figure 32. North America Interferon Beta-1a Sales Market Share in Volume by Application in 2022
Figure 33. North America Interferon Beta-1a Sales Market Share in Value by Application in 2022
Figure 34. Europe Interferon Beta-1a Sales Market Share in Volume by Application in 2022
Figure 35. Europe Interferon Beta-1a Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Interferon Beta-1a Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Interferon Beta-1a Sales Market Share in Value by Application in 2022
Figure 38. Latin America Interferon Beta-1a Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Interferon Beta-1a Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Interferon Beta-1a Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Interferon Beta-1a Manufacturing Cost Structure
Figure 43. Interferon Beta-1a Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries